Welcome to our dedicated page for Synopsys SEC filings (Ticker: SNPS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Synopsys, Inc. (SNPS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Synopsys common stock is registered on the Nasdaq Global Select Market, and the company regularly uses Form 8-K and other filings to report material events, financial results, and governance changes. These documents are central resources for understanding how Synopsys presents its business segments, strategic actions, and risk factors to investors.
Recent 8-K filings illustrate several themes that may be of interest to shareholders and analysts. One filing reports a restructuring plan approved by the board of directors, which is expected to affect approximately 10% of the workforce as of fiscal 2025 year-end. Synopsys states that this plan is intended to support investment in key growth opportunities and drive business efficiencies following the completion of its acquisition of Ansys, Inc., with substantial completion expected by the end of fiscal year 2027, subject to local requirements.
Other 8-Ks disclose topics such as the departure or appointment of certain officers, reaffirmation of financial targets, and the announcement of quarterly financial results. In its earnings-related filings and press releases, Synopsys reports revenue and net income on both GAAP and non-GAAP bases, provides reconciliations, and explains adjustments related to amortization of acquired intangible assets, stock-based compensation, acquisition and divestiture items, restructuring charges, and tax effects.
Filings also document regulatory and export control developments. For example, Synopsys reported receiving a letter from the U.S. Department of Commerce’s Bureau of Industry and Security rescinding previously imposed export restrictions related to China, and noted that it is working to restore access to affected products while assessing the impact of such restrictions on its business. Forward-looking statements sections in these filings outline risks and uncertainties related to macroeconomic conditions, industry trends, acquisitions, export controls, and other factors.
Through Stock Titan, users can review these SEC documents alongside AI-powered summaries that highlight key items such as restructuring plans, segment disclosures, export control updates, and earnings metrics. This helps readers quickly identify the portions of Synopsys’ 8-Ks, 10-Ks, 10-Qs, and related filings that are most relevant to their analysis of SNPS.
Synopsys, Inc. director and president/CEO Ghazi Sassine reported an acquisition of company stock through an employee program. On February 27, 2026, he obtained 28 shares of Synopsys common stock at $351.90 per share under the Synopsys, Inc. Employee Stock Purchase Plan. Following this transaction, his directly held common stock position increased to 74,156 shares.
SYNOPSYS INC Chief Accounting Officer Sudhindra Kankanwadi reported an acquisition of company stock through an employee plan. On 2026-02-27, Kankanwadi acquired 28.0000 shares of common stock at a price of $351.9000 per share under the Synopsys, Inc Employee Stock Purchase Plan. Following this transaction, direct holdings increased to 21714.0000 shares of Synopsys common stock.
Synopsys, Inc. has entered into a $250 million accelerated share repurchase (ASR) agreement with The Bank of Nova Scotia to buy back its common stock. Under the ASR terms, Synopsys will receive an initial delivery of approximately 513,000 shares, with any remaining shares to be settled on or before June 1, 2026. The final number of shares repurchased will depend on the average daily volume-weighted average price of Synopsys stock during the repurchase period, reduced by a discount.
Synopsys reported sharply higher revenue but much lower profit for the quarter ended January 31, 2026. Revenue rose 66% to $2.41 billion from $1.46 billion, driven mainly by the acquisition of Ansys, which contributed $885.6 million, and organic growth across most products and regions.
Despite the revenue surge, operating income fell to $203.0 million from $251.8 million, and net income attributed to Synopsys dropped to $65.0 million from $295.7 million. Diluted earnings per share declined to $0.34 from $1.89, reflecting heavy amortization of acquired intangibles, restructuring charges of $118.3 million, higher employee costs after the Ansys Merger, and much higher interest expense of $162.7 million tied to new long‑term debt.
The Design Automation segment nearly doubled revenue to $2.00 billion with a 47% adjusted operating margin, while Design IP revenue slipped to $407.0 million and its adjusted margin compressed to 16%. Cash flow from operations improved strongly to $856.8 million, even as Synopsys repaid $3.5 billion under its term loan and ended the quarter with $10.0 billion of Senior Notes outstanding and $2.13 billion in cash, cash equivalents and restricted cash.
Synopsys, Inc. reported very strong growth for the first quarter of fiscal 2026 and expanded its share repurchase capacity. Revenue rose to $2.409 billion from $1.455 billion a year earlier, reflecting major contributions from its Design Automation segment.
On a GAAP basis, net income was $65.0 million, or $0.34 per diluted share, down from $295.7 million, or $1.89 per share, largely due to higher amortization of acquired intangibles, stock-based compensation and restructuring charges. Non-GAAP net income increased to $718.5 million, or $3.77 per diluted share, from $473.2 million, or $3.03 per share.
For the second quarter of fiscal 2026, Synopsys targets revenue of $2.225–$2.275 billion and non-GAAP EPS of $3.11–$3.17. Full-year fiscal 2026 targets call for revenue of $9.56–$9.66 billion and non-GAAP EPS of $14.38–$14.46, based on an 18% non-GAAP tax rate. The board also replenished the stock repurchase program with authorization to buy up to $2.0 billion of common stock.
SYNOPSYS INC director Peter A. Shimer filed an initial ownership report on Form 3. This filing establishes his status as a reporting insider at the company and provides a baseline for any future trades. The form does not list any share purchases, sales, or other transactions.
Synopsys is asking stockholders to vote at its April 16, 2026 virtual annual meeting on five items, including electing ten directors, approving an amended and restated equity incentive plan, an advisory say-on-pay vote, ratifying KPMG as auditor, and a stockholder written-consent proposal the Board opposes.
The company highlights completion of its July 2025 acquisition of Ansys, which it says transformed Synopsys from an electronic design automation leader into a broader engineering solutions provider across industries such as automotive, aerospace, industrial and healthcare. Fiscal 2025 results included record revenue of $7.054 billion, approximately 15% year-over-year growth, GAAP operating margin of 13.0%, non-GAAP operating margin of 37.3%, operating cash flow of about $1.52 billion, free cash flow of about $1.35 billion, and backlog of $11.4 billion.
The proxy details board composition, committee responsibilities, risk oversight for areas such as cybersecurity and artificial intelligence, and executive and director compensation practices, emphasizing pay-for-performance, independent board leadership, and no increase to shares available under the equity plan while adding non-employee directors as eligible participants.
Synopsys, Inc. expanded its Board of Directors from eleven to twelve members and appointed former Deloitte executive Peter A. Shimer as a director and member of the Audit Committee, effective immediately. The Board determined he is an independent director, meets Nasdaq audit committee requirements, and qualifies as an “audit committee financial expert.”
Shimer will participate in Synopsys’ non-employee director compensation program, including an annual cash retainer of $140,000, an initial restricted stock award with a grant date fair market value of $350,000, and a prorated interim restricted stock award based on an annual $200,000 grant. Synopsys also disclosed that current directors Luis Borgen and Dr. Ajei Gopal will not be renominated and will remain on the Board through the 2026 annual meeting of stockholders.
Synopsys Inc. officer Janet Lee, GC & Corporate Secretary, reported equity award transactions on February 16, 2026. She exercised 2,873 restricted stock units into common stock at an exercise price of $0.0, increasing her direct holdings to 14,832 common shares and 5,832 RSUs.
To cover related tax obligations on the vesting, the company retained 921 common shares at a price of $437.09 per share as a tax-withholding disposition, leaving Lee with 13,911 directly owned common shares after the transaction.